Modeling cartilage pathology in mucopolysaccharidosis VI using iPSCs reveals early dysregulation of chondrogenic and metabolic gene expression

Mucopolysaccharidosis type VI (MPS VI) is a metabolic disorder caused by disease-associated variants in the Arylsulfatase B (ARSB) gene, resulting in ARSB enzyme deficiency, lysosomal glycosaminoglycan accumulation, and cartilage and bone pathology. The molecular response to MPS VI that results in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Broeders, M., van Rooij, Jgj, Oussoren, E., van Gestel, Tjm, Smith, Ca, Kimber, Sj, Verdijk, Rm, Wagenmakers, Maem, van den Hout, Jmp, van der Ploeg, At, Narcisi, R., Pijnappel, Wwmp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763729/
https://www.ncbi.nlm.nih.gov/pubmed/36561048
http://dx.doi.org/10.3389/fbioe.2022.949063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763729/
https://www.ncbi.nlm.nih.gov/pubmed/36561048
http://dx.doi.org/10.3389/fbioe.2022.949063

Ejemplares similares